Canvax Biotech
![]() |
||
Canvax is a leading manufacturer and supplier of the most innovative solutions, kits and R&D Reagents inside Molecular Biology fields. Since its foundation in 2001, Canvax offers reliable, cost-effective and easy-to-use innovative tools for research. Based in Córdoba (Spain), since its beginning it has focused on R&D of multiplex high throughput platforms (HTS) for Drug discovery and Diagnostic applied biosensors. Over a decade later, Canvax is a worldwide leading expert in GPCR expression in heterologous cells, with important patents and exclusive know-how. Canvax prides itself to be the first company to get an unprecedented milestone that could revolutionize the Diagnostics sector: Canvax established stable high-level expression of odour GPCRs into heterologous cell lines in 2014. This key milestone, that could be applied in diagnostic, perfume and cosmetic industry, are being employed to obtain a molecular nose, a sensitive and non-invasive diagnostic molecular device for early detection of cancer, as the nose of trained dogs do. Thanks to this project, Canvax was awarded, in 2013, with the largest Public & Private Contract for Pre competitive Technology Development in Spanish history. Website : www.lifescience.canvaxbiotech.com |
![SARS-CoV-2 - RT-qPCR for research and development](https://www.clinisciences.com/de/upload/thumbs/covid-19-diag-3vevev-ef7908.jpg)
SARS-CoV-2 - RT-qPCR for research and development
The COVID-19 RT-qPCR assay is based on the detection of SARS-CoV-2 RNA using a real-time RT-PCR technique with probes and primers specific to certain SARS-CoV-2 genes.
The coronavirus real-time RT-PCR nucleic acid detection kits (SARS-CoV-2) are based on the PCR method which uses a fluorescent probe and a specific primer to detect two or three specific regions within the genome of the new coronavirus (SARS-CoV-2). Typically, these are the Orf1ab, N and E genes. This detection can be done separately for each gene or in multiplex (all genes in the same reaction).
The test is performed on viral RNA extracted from nasopharyngeal swabs or salive, usually or more rarely from serum, plasma or whole blood samples from patients who may be infected with CoV-2-SARS. We also offer kits for RNA preservation in saliva samples and kits for extraction and purification of viral RNA.
The QuantiVirus Real-Time PCR Coronavirus Test kit is part of the list of official kits for the diagnosis of CoV-2-SARS in France.
Ergebnis Ihrer Suche : 4 Produkt(e) gefunden
Grenzen Sie Ihre Suche ein :
RUOCE / IVD
- kit 4
Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
E01595
100rxn(of20µL/each)
E01590
250rxnof20µL/each
‹
›